Photo

Photo detail

Stories this photo appears in:

Avalon-GlaxoSmithKline Deal Results in 1st Startup, More Planned

Avalon Ventures and GlaxoSmithKline PLC have launched their first company, Sitari Therapeutics Inc., with a $10 million Series A financing from the companies’ $495 million joint funding alliance.

Tease photo